Side Effects of Saxenda UK - Cheapest Price £48.00

Clinically Proven UK Registered Pharmacy

Side Effects of Saxenda - Cheapest UK Price £48.00

Get Saxenda at the cheapest UK price from £48.00 with £20 off using code Weightlossnew.

UK-registered clinical team
Confidential and secure
No GP visit needed
Fast and discreet delivery
Start Your Free Consultation

Takes less than 2 minutes to complete 100% online

Weightlossnew £20 off for new customers
Genuine Products
UK-licensed only
Fast Delivery
Next-day available
Expert Advice
UK pharmacists
Woman using Cured Pharmacy online consultation for weight loss treatment
£68.00 From £48.00 £20 discount using discount code Weightlossnew
LIVE PRICING

Our Pricing

Pricing Disclaimer: Prices on some pages may not be up to date — the live pricing table below and pricing shown during consultation are official current prices and take precedence over any other figures on the site.

Mounjaro Weight Loss Injections (Tirzepatide) KwikPen - UK-licensed prescription Treatment
Treatment

Mounjaro Weight Loss Injections (Tirzepatide) KwikPen

From £145.00

Future orders save 5%
Start Assessment
Wegovy (Semaglutide) Weight Loss Injection - UK-licensed prescription Treatment
Treatment

Wegovy (Semaglutide) Weight Loss Injection

From £89.00

Future orders save 5%
Start Assessment
Wegovy® Oral Tablets (Semaglutide Pill) - UK-licensed prescription Treatment
Treatment

Wegovy® Oral Tablets (Semaglutide Pill)

From £83.00

Future orders save 5%
Start Assessment
Saxenda - UK-licensed prescription Treatment
Treatment

Saxenda

From £68.00

Future orders save 5%
Start Assessment
Orlistat - UK-licensed prescription Treatment
Treatment

Orlistat

From £32.00

Future orders save 5%
Start Assessment
w
Treatment

weight loss test

From £5.00

Future orders save 5%
Start Assessment

Side Effects of Saxenda: What UK Patients Need to Know

Understanding the side effects of Saxenda is essential for anyone considering this liraglutide-based weight loss treatment in the UK. As a GLP-1 receptor agonist prescribed for chronic weight management, Saxenda is clinically proven to support weight loss, but like all prescription medicines, it can cause adverse effects that vary in severity and frequency [1]. Most patients experience mild to moderate gastrointestinal symptoms during the initial titration phase, though these typically improve as the body adjusts to the medication.

Common Side Effects of Saxenda in Clinical Trials

The most frequently reported side effects of Saxenda involve the digestive system, reflecting its mechanism of action on GLP-1 receptors in the gut and brain [1]. In the pivotal SCALE clinical trial programme involving over 5,000 participants, nausea was the most common adverse effect, reported by approximately 39% of patients taking liraglutide 3.0 mg compared to 14% on placebo [2]. Diarrhoea affected around 21% of Saxenda users, whilst constipation occurred in approximately 20% of patients during the study period.

Vomiting, dyspepsia (indigestion), and abdominal pain were also commonly observed, though these gastrointestinal side effects typically peaked during dose escalation and diminished over subsequent weeks [2]. The structured titration schedule—starting at 0.6 mg daily and increasing by 0.6 mg weekly increments—is specifically designed to minimise these effects and improve tolerability. Most patients who experience nausea find it manageable with dietary adjustments, such as eating smaller, more frequent meals and avoiding high-fat foods.

Injection site reactions represent another category of common side effects of Saxenda, with approximately 14% of trial participants reporting mild redness, itching, or bruising at the injection site [1]. These localised reactions are generally transient and resolve without intervention. Rotating injection sites between the abdomen, thigh, and upper arm—as recommended in the patient information leaflet—can significantly reduce the frequency and severity of these reactions.

Serious Side Effects of Saxenda Requiring Medical Attention

Whilst most side effects of Saxenda are mild and self-limiting, certain serious adverse events require immediate medical evaluation. Acute pancreatitis, though rare, has been reported in patients using GLP-1 receptor agonists including liraglutide [3]. Symptoms include severe, persistent abdominal pain that may radiate to the back, often accompanied by nausea and vomiting. If you experience these symptoms, discontinue Saxenda immediately and contact your GP or NHS 111 for urgent assessment.

Gallbladder disorders, including cholelithiasis (gallstones) and cholecystitis (gallbladder inflammation), occurred more frequently in Saxenda-treated patients compared to placebo in clinical trials [2]. Rapid weight loss itself is a known risk factor for gallstone formation, making it difficult to separate the medication's direct contribution from the weight loss effect. Symptoms such as sudden severe pain in the upper right abdomen, yellowing of the skin or eyes, or fever warrant immediate medical attention.

Hypoglycaemia (low blood sugar) is uncommon in patients using Saxenda alone, but the risk increases substantially when combined with other diabetes medications, particularly insulin or sulphonylureas [3]. Signs include dizziness, sweating, confusion, rapid heartbeat, and extreme hunger. Patients with type 2 diabetes require careful monitoring and potential dose adjustments of concurrent medications when starting Saxenda. Allergic reactions, whilst rare, can range from mild rash to severe anaphylaxis; any difficulty breathing, facial swelling, or widespread urticaria requires emergency medical care.

Thyroid Concerns and Saxenda Use

Liraglutide carries a boxed warning regarding thyroid C-cell tumours based on rodent studies, though no causal relationship has been established in humans [3]. Saxenda is contraindicated in patients with a personal or family history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2). During your clinical assessment at Cured Pharmacy, our UK-registered prescribers carefully screen for these contraindications to ensure safe prescribing. Patients should report any neck lumps, persistent hoarseness, difficulty swallowing, or shortness of breath to their healthcare provider promptly.

Managing the Side Effects of Saxenda: Practical Strategies

Effective management of the side effects of Saxenda can significantly improve treatment adherence and overall experience. For gastrointestinal symptoms, dietary modifications prove highly effective: consuming smaller portions more frequently throughout the day reduces stomach distension and nausea [4]. Avoiding fatty, fried, or heavily spiced foods during the initial weeks helps minimise digestive upset, as does staying well-hydrated with water and clear fluids.

Taking Saxenda at a consistent time each day—many patients prefer evening administration—can help the body establish a predictable rhythm and may reduce daytime nausea. If nausea persists despite these measures, ginger supplements or anti-emetic medications prescribed by your GP may provide relief. Never increase your Saxenda dose until gastrointestinal symptoms from the current dose have substantially resolved; the weekly titration schedule exists precisely to allow your body time to adapt.

For injection site reactions, proper technique is paramount. Allow the Saxenda pen to reach room temperature before injecting, clean the site with an alcohol wipe, and use a fresh needle for each injection. Rotate sites systematically rather than using the same location repeatedly. If bruising occurs, applying gentle pressure (without rubbing) immediately after injection can minimise discolouration. Most injection-related side effects of Saxenda improve markedly as patients become more confident with the technique.

When to Contact Your Prescriber

Certain symptoms warrant direct communication with your prescriber or GP. Persistent vomiting that prevents adequate fluid intake risks dehydration and electrolyte imbalance. Severe or worsening abdominal pain, particularly if accompanied by fever, requires same-day medical evaluation to rule out pancreatitis or gallbladder complications [3]. Changes in heart rate, especially a sustained resting heart rate increase of more than 10-15 beats per minute, should be reported, as tachycardia has been observed in some Saxenda users. At Cured Pharmacy, our clinical team remains available to address concerns and adjust treatment plans as needed throughout your weight loss journey.

Treatment Active Ingredient Administration Starting Price
Saxenda Liraglutide 3.0 mg Daily injection from £68.00
Wegovy Semaglutide Weekly injection from £89.00
Mounjaro Tirzepatide Weekly injection from £145.00
Orlistat Orlistat 120 mg Three times daily oral from £32.00
Xenical Orlistat 120 mg Three times daily oral from £49.99

Comparing Side Effects of Saxenda to Other Weight Loss Treatments

When evaluating the side effects of Saxenda against alternative weight loss medications available in the UK, the gastrointestinal symptom profile differs notably between drug classes. Orlistat (Xenical, Alli) causes fat malabsorption, leading to oily stools, faecal urgency, and anal leakage—side effects mechanistically distinct from Saxenda's GLP-1-mediated nausea and delayed gastric emptying [4]. Patients who cannot tolerate fatty stool changes with orlistat may find Saxenda's nausea more manageable, and vice versa.

Newer GLP-1 receptor agonists like semaglutide (Wegovy) and tirzepatide (Mounjaro) share a similar side effect spectrum with Saxenda, as they act on the same receptor pathways. However, dosing frequency differs: Saxenda requires daily subcutaneous injection, whilst Wegovy and Mounjaro are administered weekly, potentially offering convenience advantages [5]. Gastrointestinal side effects occur with all three medications, though individual tolerance varies. Some patients who experience intolerable nausea on one GLP-1 agonist may tolerate another better, though switching should only occur under medical supervision.

The side effects of Saxenda must be weighed against its proven efficacy: in the SCALE Obesity and Prediabetes trial, patients lost an average of 8% of their initial body weight over 56 weeks compared to 2.6% with placebo [2]. This clinically meaningful weight reduction, combined with improvements in cardiovascular risk factors, often justifies tolerating transient gastrointestinal symptoms for many patients. Your prescriber will help determine whether Saxenda's benefit-risk profile aligns with your individual health status, weight loss goals, and tolerance for potential adverse effects.

Long-Term Side Effects of Saxenda: What Research Shows

Long-term safety data for the side effects of Saxenda extends beyond three years from extension phases of the SCALE clinical trial programme [2]. Gastrointestinal adverse effects, whilst common during initial titration, typically diminish substantially after the first 12-16 weeks of treatment. In the three-year SCALE Obesity and Prediabetes study, discontinuation rates due to adverse events were highest in the first six months and declined thereafter, suggesting improved tolerability with continued use.

Cardiovascular safety represents a critical consideration for any obesity medication. The LEADER trial, which studied liraglutide 1.8 mg in patients with type 2 diabetes, demonstrated cardiovascular safety and even suggested potential benefit, though this was at a lower dose than the 3.0 mg used for weight management [5]. Heart rate increases of 2-3 beats per minute above baseline were observed and persisted throughout treatment, though this modest elevation did not translate to increased cardiovascular events in clinical trials. Patients with pre-existing cardiovascular conditions require individualised risk assessment before starting Saxenda.

Bone health, nutrient absorption, and metabolic parameters have been monitored in long-term Saxenda users without signals of significant concern [4]. Unlike some historical weight loss medications, liraglutide does not appear to cause valvular heart disease or pulmonary hypertension. Ongoing post-marketing surveillance by the MHRA continues to monitor for rare or delayed adverse effects not apparent in clinical trials. At Cured Pharmacy, we provide Saxenda at £48.00 per pen, with £20 off your first order using code Weightlossnew, ensuring UK patients access this clinically-proven treatment at the cheapest UK price whilst maintaining rigorous safety standards through our online prescriber assessments.

Renal and Hepatic Considerations

Patients with kidney or liver impairment require special consideration regarding the side effects of Saxenda. Severe gastrointestinal symptoms leading to dehydration can precipitate acute kidney injury, particularly in patients with pre-existing renal disease [3]. Dose adjustments are not routinely required for mild to moderate renal or hepatic impairment, but clinical monitoring is essential. Saxenda is not recommended for patients with severe renal impairment (eGFR <30 mL/min/1.73m²) or end-stage renal disease due to limited safety data in these populations.

Who Should Avoid Saxenda Due to Side Effect Risks

Certain patient populations face elevated risks from the side effects of Saxenda and should not use this medication. Absolute contraindications include personal or family history of medullary thyroid carcinoma, Multiple Endocrine Neoplasia syndrome type 2, previous serious hypersensitivity to liraglutide or any excipients, and pregnancy or breastfeeding [1]. Women of childbearing potential should use effective contraception during treatment and discontinue Saxenda at least two months before planned conception.

Patients with inflammatory bowel disease or diabetic gastroparesis may experience worsening gastrointestinal symptoms due to Saxenda's effect on gastric emptying [3]. Those with a history of pancreatitis face increased risk of recurrence, though the causal relationship remains debated in medical literature. Severe, unstable cardiovascular disease warrants caution, as does concurrent use of other GLP-1 receptor agonists or DPP-4 inhibitors. Age under 18 years represents another contraindication, as safety and efficacy have not been established in paediatric populations.

During the online clinical assessment at Cured Pharmacy, our UK-registered prescribers systematically screen for these contraindications and relative precautions. Patients taking medications that slow gastric emptying, such as opioid analgesics, may require additional monitoring due to potential interaction effects. Mental health history, particularly depression with suicidal ideation, requires careful consideration, as mood changes have been reported in some patients using weight loss medications [4]. Our prescribers balance the potential benefits of Saxenda against individual risk factors to ensure safe, appropriate prescribing aligned with MHRA guidelines and NICE recommendations for obesity management.

Scientific References

  1. Pi-Sunyer, X., Astrup, A., Fujioka, K., Greenway, F., Halpern, A., Krempf, M., ... & Wilding, J. P. (2015). A randomized, controlled trial of 3.0 mg of liraglutide in weight management. New England Journal of Medicine, 373(1), 11-22.
  2. Wadden, T. A., Hollander, P., Klein, S., Niswender, K., Woo, V., Hale, P. M., & Aronne, L. (2013). Weight maintenance and additional weight loss with liraglutide after low-calorie-diet-induced weight loss: the SCALE Maintenance randomized study. International Journal of Obesity, 37(11), 1443-1451.
  3. Medicines and Healthcare products Regulatory Agency. (2021). Saxenda 6 mg/ml solution for injection in pre-filled pen: Summary of Product Characteristics. Retrieved from https://www.medicines.org.uk/emc/product/2313/smpc
  4. Blackman, A., Foster, G. D., Zammit, G., Rosenberg, R., Aronne, L., Wadden, T., ... & Mignot, E. (2016). Effect of liraglutide 3.0 mg in individuals with obesity and moderate or severe obstructive sleep apnea: the SCALE Sleep Apnea randomized clinical trial. International Journal of Obesity, 40(8), 1310-1319.
  5. Marso, S. P., Daniels, G. H., Brown-Frandsen, K., Kristensen, P., Mann, J. F., Nauck, M. A., ... & Poulter, N. R. (2016). Liraglutide and cardiovascular outcomes in type 2 diabetes. New England Journal of Medicine, 375(4), 311-322.

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication.

How it Works?

Select from our recommended UK-licensed medications.

1

Choose your treatment

Step 1: Choose your treatment from Cured Pharmacy

Select safe UK treatments. Quick answers.

2

Answer quick questions

Step 2: Answer quick consultation questions

We will deliver direct to you as quickly as tomorrow.

3

Get it delivered fast

Step 3: Fast discreet delivery to your door

Start Your Assessment For Weight Loss

Start your journey to better health today.

  • Reviewed by UK-based prescribers
  • Takes under 3 minutes
  • Discreet Packaging

Start Your Journey To Better Health Today

Once you complete a short online assessment you will be able to choose your preferred treatment from safe medically approved options tailored to you.

Start My Assessment

Returning Customer?

Log in to Your Account

Faq

How long do the side effects of Saxenda typically last?
Most gastrointestinal side effects of Saxenda, including nausea and diarrhoea, peak during the first 4-8 weeks of treatment and gradually diminish as your body adjusts to the medication. Injection site reactions typically resolve within days, whilst the slow titration schedule helps minimise symptom severity.
Can I take anti-nausea medication with Saxenda?
Yes, anti-emetic medications can be prescribed alongside Saxenda if nausea persists despite dietary modifications. Consult your GP or prescriber before adding any new medication, as some anti-nausea drugs may interact with Saxenda or affect its absorption and efficacy.
Are the side effects of Saxenda worse than Wegovy or Mounjaro?
The side effects of Saxenda are similar to other GLP-1 receptor agonists like Wegovy and Mounjaro, with nausea, vomiting, and diarrhoea being common across all three medications. Individual tolerance varies, and some patients find one medication more tolerable than another, though all share the same mechanism of action.
Will the side effects of Saxenda stop if I reduce my dose?
Reducing your Saxenda dose may alleviate side effects, but this should only be done under medical supervision. The titration schedule is designed to reach the therapeutic 3.0 mg dose gradually; if side effects persist at a lower maintenance dose, your prescriber may recommend staying at that level longer before increasing.
Does everyone experience side effects with Saxenda?
No, not all patients experience side effects of Saxenda. In clinical trials, approximately 39% reported nausea, meaning the majority either had no nausea or only mild symptoms. Individual responses vary based on factors including titration speed, diet, and personal sensitivity to GLP-1 receptor agonists.
Can Saxenda cause hair loss or thinning?
Hair loss is not a commonly reported side effect of Saxenda in clinical trials. However, rapid weight loss from any cause can trigger temporary hair thinning (telogen effluvium) due to nutritional shifts and metabolic stress, which typically resolves once weight stabilises.
Are there any foods I should avoid to reduce Saxenda side effects?
To minimise gastrointestinal side effects of Saxenda, avoid high-fat, fried, and heavily spiced foods, particularly during the initial titration phase. Smaller, more frequent meals with lean proteins, vegetables, and whole grains are generally better tolerated and help reduce nausea and bloating.
What should I do if I experience severe abdominal pain on Saxenda?
Severe or persistent abdominal pain whilst taking Saxenda requires immediate medical evaluation to rule out pancreatitis or gallbladder complications. Discontinue your injections and contact your GP, NHS 111, or attend A&E if the pain is accompanied by vomiting, fever, or radiates to your back.
Tarun Kumar, Prescribing Pharmacist

Medically reviewed by

Tarun Kumar, Prescribing Pharmacist (GPhC 2233073)

Last reviewed: 31 July 2026